Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Csernok

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Thorax|September 20, 2001
CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosisP Lamprecht, F Moosig, E Csernok, et al.
Clinical and Experimental Immunology|July 1, 1995
Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulinC Richter, A Schnabel, E Csernok, et al.
Annals of the Rheumatic Diseases|March 15, 2001
Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitisP Lamprecht, F Moosig, A Gause, et al.
Annals of the Rheumatic Diseases|January 29, 2010
Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmatic antibodies directed against proteinase 3J U Holle, E Csernok, G Fredenhagen, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseasesS Hauschild, W H Schmitt, E Csernok, et al.
Blood|August 15, 1993
Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosisW J Mayet, E Csernok, C Szymkowiak, et al.
Experimental and Clinical Immunogenetics|January 1, 1997
Polymorphisms in the tumor necrosis factor genes in Wegener's granulomatosisB Mascher, W Schmitt, E Csernok, et al.
Clinical and Experimental Immunology|July 1, 1996
Transforming growth factor-beta (TGF-beta) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitisE Csernok, C H Szymkowiak, N Mistry, et al.
Clinical and Experimental Immunology|April 1, 1996
Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disordersM P Stoffel, E Csernok, C Herzberg, et al.
The Netherlands Journal of Medicine|April 1, 1990
Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis: immunodiagnostic value, monoclonal antibodies and characterization of the target antigenJ Lüdemann, E Csernok, M Ulmer, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Thorax|September 20, 2001
CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosisP Lamprecht, F Moosig, E Csernok, et al.
Clinical and Experimental Immunology|July 1, 1995
Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulinC Richter, A Schnabel, E Csernok, et al.
Annals of the Rheumatic Diseases|March 15, 2001
Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitisP Lamprecht, F Moosig, A Gause, et al.
Annals of the Rheumatic Diseases|January 29, 2010
Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmatic antibodies directed against proteinase 3J U Holle, E Csernok, G Fredenhagen, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseasesS Hauschild, W H Schmitt, E Csernok, et al.
Blood|August 15, 1993
Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosisW J Mayet, E Csernok, C Szymkowiak, et al.
Experimental and Clinical Immunogenetics|January 1, 1997
Polymorphisms in the tumor necrosis factor genes in Wegener's granulomatosisB Mascher, W Schmitt, E Csernok, et al.
Clinical and Experimental Immunology|July 1, 1996
Transforming growth factor-beta (TGF-beta) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitisE Csernok, C H Szymkowiak, N Mistry, et al.
Clinical and Experimental Immunology|April 1, 1996
Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disordersM P Stoffel, E Csernok, C Herzberg, et al.
The Netherlands Journal of Medicine|April 1, 1990
Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis: immunodiagnostic value, monoclonal antibodies and characterization of the target antigenJ Lüdemann, E Csernok, M Ulmer, et al.
Pageof 11